Clinical Trial Update: Efficacy and Safety of the CG-100 Intraluminal Bypass Device [NA]

View source ↗

Summary

The document provides a trial update for the CG-100 intraluminal bypass device, noting that recruitment is ongoing for rectal cancer-related indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Rectal Cancer

Drugs mentioned

• CG-100 Intraluminal Bypass Device

Snippet

Sponsor: Colospan Ltd. | Conditions: Rectal Cancer, Rectal Tumor | NA | Status: RECRUITING